Interesting paper, perhaps immunotherapy for advanced cancer reduces the risk of developing other new malignancies, potential implications for future use of IO in early stage cancer #LCSM
Reduced risk of 2nd primary cancer after treatment with anti-PD1 Ab. small study, but it provides a ground to knock the door of big ERH dara collections to test it in large number